El interés en corto de Pliant Therapeutics da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Pliant Therapeutics. Los datos de interés en corto se actualizan cada dos semanas.

Pliant Therapeutics (NASDAQ:PLRX) Bolsa, Informe de interés en corto

PLIANT THERAPEUTICS INC

Pliant Therapeutics

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Pliant Therapeutics Inc

POET Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POET#NASDAQ">POET</a>) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.07) by 214.29 percent. This is a 166.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $166.76 thousand which missed the analyst consensus estimate of $400.00 thousand by 58.31 percent. This is a 1.81K percent increase over sales of $8.71 thousand the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

POET

POET Technologies Q1 EPS $0.08 Beats $(0.07) Estimate, Sales $166.76K Miss $400.00K Estimate

Sigma Lithium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGML#NASDAQ">SGML</a>) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01 by 300 percent. This is a 166.67 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $47.67 million which missed the analyst consensus estimate of $50.75 million by 6.06 percent. This is a 27.47 percent increase over sales of $37.40 million the same period last year.

SGML

Sigma Lithium Q1 EPS $0.04 Beats $0.01 Estimate, Sales $47.67M Miss $50.75M Estimate

CYCC

Cyclacel Reports $0.1M Q1 Loss, Refocuses On Oral Plogosertib And Seeks Strategic Options After UK Exit

Automotive Props REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/APR#TSX">APR</a>) reported quarterly earnings of $0.25 per share. This is a 5.56 percent increase over earnings of $0.23 per share from the same period last year. The company reported $23.90 million in sales this quarter. This is a 2.09 percent increase over sales of $23.41 million the same period last year.

TSX:APR

Automotive Props REIT Q1 FFO $0.25 Up From $0.23 YoY, Sales $23.90M Up From $23.41M YoY

<ul>
<li>Up to 300 R&amp;D jobs could initially be created in Japan, highlighting the country's strategic importance to Ericsson</li>
<li>Investment to support Japan's connectivity ecosystem of partners, suppliers and customers globally</li>
<li>R&amp;D innovation to help accelerate the build-out of national digital infrastructure, through deployment of open high-performing programmable networks</li>
</ul>

ERIC

Ericsson Commits To R&D Investment In Japan, Plans To Create Up To 300 High-Skilled Telecom Jobs

General Motors Co.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) has announced the development of a revolutionary EV battery technology, aiming to secure a leading position in the market with its cost-effective solution for large electric SUVs and trucks.
What Happened: GM is spearheading a unique EV battery technology that is set to reduce costs and boost the profitability of its largest electric vehicles. The new lithium manganese-rich (LMR) prismatic battery cells are anticipated to be integrated into full-size electric vehicles, such as the Chevrolet Silverado and Escalade IQ, beginning in 2028, <a href="https://www.cnbc.com/2025/05/13/gm-new-ev-battery-tech.html">reported</a> CNBC.
The innovative batteries employ more abundant and less expensive minerals such as manganese, replacing larger quantities of cobalt and nickel&nbsp;used in EV batteries at present. This shift in battery chemistry influences several factors, including the range, safety, energy efficiency and charging capabilities of EVs.
&#8220;LMR unlocks the premium range&nbsp;and performance at an affordable&nbsp;cost,&#8221; stated&nbsp;Kurt Kelty,&nbsp;the vice president of battery,&nbsp;propulsion, sustainability at General Motors. He further described it as a &#8220;game-changing battery for electric trucks.&#8221;
GM is developing its new battery technology in collaboration with LG Energy Solution. Ultium Cells, the joint venture, aims to begin commercial production of LMR prismatic cells in the U.S. by 2028, with preproduction set to start at an LG Energy Solution facility by late 2027.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/05/45314762/charlie-munger-was-once-asked-why-warren-buffett-was-so-much-richer-and-replied-he-got-an-earlier-start-before-adding-why-was-albert-einstein-poorer-than-i-was" target="_blank" rel="noreferrer noopener">Charlie Munger Was Once Asked Why Warren Buffett Was So Much Richer — He Replied, &#8216;He Got An Earlier Start,&#8217; Then Added, &#8216;Why Was Albert Einstein Poorer Than I Was?&#8217; &#8211; Benzinga</a>
Why It Matters: This announcement comes at a critical time for GM. Earlier in May, the company had to&nbsp;<a href="https://www.benzinga.com/news/earnings/25/05/45150325/gm-cut-its-2025-forecast-on-tariffs-but-core-business-holds-up-says-goldman-sachs">revise its 2025 forecast</a>&nbsp;due to tariff uncertainty, impacting its estimated earnings by $4.0 billion to $5.0 billion. 
Furthermore, the federal EV credit program, a significant incentive for EV buyers, is under threat of being&nbsp;<a href="https://www.benzinga.com/tech/25/05/45277309/house-gop-representatives-want-to-axe-federal-ev-credit-amid-trumps-tax-cuts-report">eliminated by House Republicans</a>. In this context, GM&#8217;s new battery technology could be a game-changer, potentially reducing costs and increasing the appeal of its EVs, thereby boosting sales and offsetting these challenges.
In March, a Reuters report revealed that Hyundai Motors and General Motors are nearing a deal where Hyundai would supply two electric commercial van models to GM, while GM may provide pickup trucks for Hyundai to sell under its brand in North America. The talks could lead to a broader partnership, including joint efforts in chip procurement, next-gen batteries and battery materials.
Benzinga&#8217;s Edge Rankings place General Motors in the 80th percentile for quality and the 91st percentile for value, reflecting its strong performance in both areas.&nbsp;<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener">Check the detailed report here.</a>
Over the past 5 days, GM stock climbed 8.87%, while year to date it dropped over 2%.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/25/04/45091619/paypal-says-its-moving-quickly-on-crypto-stablecoinfintech-giant-partners-with-coinbase-to-boost-pyusd" target="_blank" rel="noreferrer noopener">PayPal CEO Says &#8216;Moving Quickly&#8217; To Bring Crypto, Stablecoin Benefits To Users — Fintech Giant Partners With Coinbase To Boost Solana-based PYUSD &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

General

GM's New Battery Chemistry Aims To Slash EV Costs And Deliver Affordable High-Performance Electric Trucks

As of May 26th 2025, e.l.f. Cosmetics and e.l.f. SKIN products will be available in 776 Kruidvat and 183 Trekpleister stores nationwide in The Netherlands and 271 Kruidvat stores in Belgium. The community can also shop e.l.f. products online on kruidvat.nl, kruidvat.be and trekpleister.nl, starting with e.l.f. Cosmetics on May 26th and e.l.f. SKIN on June 2nd 2025.

e.l.f. Beauty Expands In The Netherlands And Belgium With KRUIDVAT And TREKPLEISTER Launches, Strengthening Global Footprint

Nexus Ind REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/NXR#TSX">NXR</a>) reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.19 by 19.47 percent. This is a 14.18 percent increase over earnings of $0.13 per share from the same period last year. The company reported $44.75 million in sales this quarter. This is a 7.59 percent increase over sales of $41.60 million the same period last year.

TSX:NXR

Nexus Ind REIT Q1 FFO $0.15 Misses $0.19 Estimate, Sales $44.75M Up From $41.60M YoY

IPHA

Innate Pharma Announces Selection Of IPH6501 ANKET Abstract For EHA 2025, Emphasizing Novel NK Cell Engagement Strategy

G Mining Ventures (TSX:<a class="ticker" href="https://www.benzinga.com/stock/GMIN#TSX">GMIN</a>) reported quarterly earnings of $0.16 per share. This is a 1700 percent increase over losses of $(0.01) per share from the same period last year. The company reported $98.02 million in sales this quarter.

TSX:GMIN

G Mining Ventures Q1 EPS $0.16 Up From $(0.01) YoY, Sales $98.02M

HIVE

HIVE Digital Surpasses 8 EH/s In Global Bitcoin Hashrate, On Track For 11.5 EH/s By June And 25 EH/s In Q4 2025

YouTube is leveraging Google&#8216;s Gemini artificial intelligence technology to help advertisers target viewers precisely when they&#8217;re most captivated, potentially boosting ad effectiveness and creator revenue.
What Happened: The video platform announced &#8220;Peak Points,&#8221; a new AI-powered tool that identifies moments of heightened viewer engagement and strategically places ads immediately after these attention peaks. 
Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) unveiled the feature Wednesday at its YouTube Brandcast event in New York.
Peak Points analyzes video elements, including frames and transcripts, to determine optimal ad placement timing. Currently in pilot phase, the technology will roll out more broadly throughout the year.
See Also:&nbsp;<a href="https://www.benzinga.com/general/health-care/25/05/45426769/unitedhealth-stock-plunges-over-8-in-after-hours-trading-as-doj-criminal-probe-adds-to-turmoil-after-ceo-shake-up" target="_blank" rel="noreferrer noopener">UnitedHealth Stock Plunges Over 8% In After-Hours Trading As DOJ Criminal Probe Adds To Turmoil After CEO Shake-Up</a><a href="https://www.benzinga.com/go/plus500-futures" target="_blank" rel="noreferrer noopener"></a>
Why It Matters: The tool represents another step in Alphabet&#8217;s AI monetization strategy amid its broader push to integrate artificial intelligence across its product ecosystem. This comes as the <a href="https://www.benzinga.com/25/04/44995955/alphabet-q1-earnings-highlights-google-search-youtube-cloud-show-robust-momentum">company reported first-quarter revenue</a> of $90.23 billion, up 12% year-over-year, with YouTube ad revenue reaching $8.9 billion, up from $8.1 billion in the previous year.
Google&#8217;s AI initiative extends beyond advertising. Last week, the company deployed on-device Gemini Nano to detect and <a href="https://www.benzinga.com/markets/equities/25/05/45314987/google-deploys-on-device-gemini-ai-to-fight-online-scams-blocks-millions-of-fraud-pages-in-real-time">block fraudulent websites in real-time</a> across Chrome, Search and Android systems—blocking millions of scam pages daily.
This AI-driven advertising enhancement arrives as competition intensifies in the search market, with AI startup Perplexity recently <a href="https://www.benzinga.com/news/financing/25/05/45358069/perplexitys-14-billion-valuation-ignites-google-search-engine-shakeup">valued at $14 billion</a>, up from $9 billion just six months ago, positioning it as a potential challenger to Google&#8217;s search dominance.
Photo Courtesy: Shutterstock.com
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/05/45428241/elon-musks-grok-ai-got-asked-how-many-times-has-hbo-changed-its-name-leaves-user-stunned-with-racially-charged-response" target="_blank" rel="noreferrer noopener">Elon Musk's Grok AI Got Asked How Many Times Has HBO Changed Its Name, Leaves User Stunned With Racially Charged Response</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

GOOG

GOOGL

YouTube's Gemini AI Tool Knows When You're Most Hooked — And That's When The Ads Hit

Macro Economic Events

Econ #s

Economics

U.K. Business Investment (QoQ) Preliminary For Q1 5.9% Vs. 0.4% Est.; -1.9% Prior

U.K. Gross Domestic Product (QoQ) Preliminary For Q1 0.7% Vs. 0.6% Est.; 0.1% Prior

U.K. Gross Domestic Product (MoM) For March 0.2% Vs. 0.0% Est.; 0.5% Prior

U.K. Gross Domestic Product (YoY) Preliminary For Q1 1.3% Vs. 1.2% Est.; 1.5% Prior

U.K. Industrial Production (MoM) For March -0.7% Vs. -0.6% Est.; 1.7% (Revised) Prior

U.K. Manufacturing Production (MoM) For March -0.8% Vs. -0.8% Est.; 2.4% (Revised) Prior

U.K. Monthly Gross Domestic Product (GDP) 3M/3M Change For March 0.7% Vs. 0.6% Est.; 0.6% Prior

U.K. Trade Balance For March -19.87B Vs. -19.10B Est.; -20.96B (Revised) Prior

Health Care

Press Releases

Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

Legal

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics – PLRX

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics

Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. – PLRX

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

Comments

Pliant Therapeutics

Interés en corto

Pliant Therapeutics (NASDAQ:PLRX) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL